Alkaloid AD Skopje operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Alkaloid AD Skopje with three other
pharmaceutical manufacturers in Europe:
Eckert & Ziegler Strahlen- und Medizinte
sales of 178.49 million Euros [US$196.36 million]
of which 59%
was Isotope Products),
Deva Holding AS
(1.37 billion Turkish Liras [US$202.84 million]
of which 93%
was Pharmaceuticals), and
Karo Pharma AB
based in SWEDEN
(1.90 billion Swedish Kronor [US$197.52 million]
of which 100%
was Drugs Discovery & Dev).
Alkaloid AD Skopje reported sales of 11.10 billion Macedonian Denars (US$198.30 million)
December of 2019.
increase of 13.5%
versus 2018, when the company's sales were 9.78 billion Macedonian Denars.
Sales at Alkaloid AD Skopje have increased during each of the previous five years
(and since 2014, sales have increased a total of 50%).
Sales of Botanicals saw an increase
that was more than double the company's growth rate: sales were up
41.0% in 2019, from
291.74 million Macedonian Denars to 411.38 million Macedonian Denars.
Not all segments of Alkaloid AD Skopje experienced an increase in sales in 2019:
sales of Cosmetics fell 2.3% to 878.22 million Macedonian Denars.